Current Perspectives on the Impact of the National Diabetes Prevention Program: Building on Successes and Overcoming Challenges
Open accessAbstract
To address the public health and economic burden of type 2 diabetes, the Centers for Disease Control and Prevention (CDC) began dissemination of the National Diabetes Prevention Program (NDPP) in the United States in 2010. Based on the intensive lifestyle intervention from a large efficacy trial, the NDPP aims to reduce incidence through lifestyle change and weight loss. This narrative review summarizes evidence on reach, effectiveness, and sustainability of the NDPP, while highlighting opportunities to overcome challenges in these areas. Major successes include reaching hundreds of thousands of at-risk individuals across the nation, with notable effectiveness upon full participation and widespread insurance coverage. Yet, more work is needed to ensure greater public health impact, particularly among priority populations at heightened risk who also experience disparities in program outcomes. Preliminary evidence suggests a number of strategies may improve reach and effectiveness of the NDPP, often with more rigorous study needed prior to widespread uptake. Updating the NDPP to better match the current evidence-base may also be important, such as directly targeting glycemia with a patient-centered approach and promoting metformin as an adjunct or second-line treatment. Finally, revisiting pay-for-performance reimbursement models may be critical to sustainability by ensuring adequate availability of suppliers and ultimately reducing diabetes prevalence.
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review summarizes the reach, effectiveness, and sustainability of the CDC’s National Diabetes Prevention Program (NDPP) since its 2010 dissemination. It highlights substantial scaling and payer coverage but concludes that reach, outcomes, and supplier sustainability remain insufficient for population-level impact, especially among priority populations.
Key findings
- Reach grew from about 35,000 eligible participants served as of 2016 to over 324,000 by early 2019, with over 1,500 NDPP sites as of 2020 across all 50 states, the District of Columbia, and most US territories; online delivery exceeds in-person reach despite later approval.
- Effectiveness is promising but incomplete: mean weight loss was 4.2% for in-person NDPP classes and 4.3% for virtual programs, yet 71.7% of participants did not achieve the ≥5% weight loss goal; each session attended was associated with 0.3% more weight loss, and median attendance was only 134 days.
- Disparities persist: only 24.7% of participants were men, average participant age was 55.1, initial no-shows ranged from 25–60% and were higher for racial/ethnic minority, low-income, and younger participants, and women, younger adults, and racial/ethnic minority and low-income participants lost about half as much weight as their counterparts.
- Sustainability is threatened by low reimbursement: private-payer delivery costs were 275–425 USD per participant versus average reimbursement of 212 USD; Medicare first-year in-person costs were 553–800 USD versus reimbursement of 108–190 USD; Minnesota Medicaid costs were 767–915 USD versus estimated average reimbursement of 163 USD; over 3,000 organizations provided the NDPP between 2012–2019, but only half remained in 2020.
Methods
- Design: narrative review of recent literature and reports on NDPP dissemination in the US, organized around reach, effectiveness, and sustainability.
- Data: published studies, CDC reports and registries, payer/coverage reports, and other program evaluations; no systematic search or meta-analytic pooling is described.
- Analysis: narrative synthesis of successes and challenges, with suggested strategies summarized in Table 1.
Limitations
- The paper does not include a formal limitations section. It states that incident type 2 diabetes has not yet been systematically examined as a program outcome, that effectiveness in terms of glycemia and incident diabetes is largely unknown, and that more rigorous study is needed before widespread uptake of many proposed strategies.
- Evident from the text: as a narrative review, it does not describe a systematic search strategy, inclusion criteria, or risk-of-bias assessment, and it relies on heterogeneous reports with varying outcome definitions and revised CDC evaluation standards over time.
- Evident from the text: outcome data are typically examined only for participants who attend a minimum number of sessions or have a minimum number of recorded weights, which may bias retention and weight-loss estimates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
15 of 35 cited sources checked · 9 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Population reach increased from about 35,000 eligible participants as of 2016 to over 324,000 by early 2019.
“In turn, population reach has been fast increasing from about 35,000 eligible participants served as of 20163 to over 324,000 by early 2019.10”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [3] Ely, 2017, Diab Care source
- cites [10] Gruss, 2019, Curr Diab Rep source
The “Analysis Sample” section reports that more than 297,000 people attended at least one National DPP session through January 2019, supporting substantial reach by early 2019. It does not establish the cited figure of over 324,000. The 2016 figure has a separate citation in the citing sentence and is not assessed against this source. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Online delivery exceeds the reach of in-person NDPP programs.
“Indeed, despite fewer online than in-person NDPP suppliers7 and later approval for dissemination, online delivery exceeds the reach of in-person programs.10”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [7] CDC. Diabetes prevention recognition program registry of recognized organizations. Available from: https://nccd.cdc.gov/DDT_DPRP/Registry.aspx. Accessed April 8, 2020.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [10] Gruss, 2019, Curr Diab Rep source
- Premisecitation
For a private payer example, cost of delivering an early version of the in-person NDPP appeared to range from 275-425 USD per participant with average reimbursement of 212 USD, leaving a gap of 63-213 USD.
“For a private payer example, cost of delivering an early version of the in-person NDPP appeared to range from 275–425 USD per participant68 with average reimbursement of 212 USD,59 leaving a gap of 63–213 USD.”
Quote in the paperSubstantial claim1 of 2 sources checked - Interpretationcitation
MDPP site shortages in states with the largest racial/ethnic minority populations continue patterns observed with NDPP availability.
“continuing patterns observed with NDPP availability.11”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [11] Jayapaul-Philip, 2018, Prev Chronic Dis source
The Main Findings report fewer National DPP class locations in counties with higher diabetes incidence or greater socioeconomic disadvantage. The paper does not analyze availability by state racial or ethnic minority population, so it does not establish that the specific MDPP site-shortage pattern described here was previously observed for the National DPP. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
Each session attended is associated with 0.3% more weight loss.
“Improving retention appears key overall to ensuring beneficial weight loss outcomes (e.g., each session attended is associated with 0.3% more weight loss).3”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [3] Ely, 2017, Diab Care source
- Premisecitation
Nearly 50 insurers began to cover NDPP services by 2016.
“Subsequently, nearly 50 insurers began to cover NDPP services by 2016.14”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [14] Nhim, 2019, Impl Sci source
- Premisecitation
Approximately half of organizations that provided the NDPP between 2012 and 2019 remained in 2020.
“Half of suppliers who previously offered the NDPP appear to have since extinguished their services.”
- Also stated in: § Overcoming Challenges with Payer Coverage · plain
“Over 3000 organizations provided the NDPP between 2012–2019,10 whereas only half remain in 2020.7”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [10] Gruss, 2019, Curr Diab Rep source
The US National DPP—a Case Study reports more than 3,000 participating organizations as of April 2019, but gives no count of organizations that later stopped offering the program. A search for organization attrition and discontinued services found no passage supporting the claim that half had ceased by 2020. (LLM, conf=0.77)
Experimental — accuracy not yet measured - cites [7] CDC. Diabetes prevention recognition program registry of recognized organizations. Available from: https://nccd.cdc.gov/DDT_DPRP/Registry.aspx. Accessed April 8, 2020.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Also stated in: § Overcoming Challenges with Payer Coverage · plain
- Premisecitation
Over 3000 organizations provided the NDPP between 2012 and 2019.
“Over 3000 organizations provided the NDPP between 2012–2019,10”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [10] Gruss, 2019, Curr Diab Rep source
- Premisecitation
Nearly three-quarters of participants (71.7%) do not achieve the ≥5% weight loss goal according to a CDC report.
“Nearly three-quarters of participants (71.7%) do not achieve the ≥5% weight loss goal according to a CDC report.10”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [10] Gruss, 2019, Curr Diab Rep source
Table 1 in the Results reports that 68.6% of the analyzed National DPP participants lost less than 5% of their weight. This supports the point that most did not meet the goal, but not the attributed figure of 71.7%. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Few adults with prediabetes are aware of their condition (15.3%).
“An upstream issue is that few adults with prediabetes are aware of their condition (15.3%),1 although it is encouraging that risk awareness has been increasing over time.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1] CDC. National Diabetes Statistics Report, 2020: Estimates of Diabetes and Its Burden in the United States. Atlanta:GA: US Department of Health and Human Services; 2020.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The NDPP has achieved over 1,500 sites as of 2020.
“The NDPP has achieved impressive scaling with over 1,500 sites as of 2020, per the CDC’s registry of organizations participating in their Diabetes Prevention and Recognition Program (DPRP) that monitors fidelity and quality.7,8”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [7] CDC. Diabetes prevention recognition program registry of recognized organizations. Available from: https://nccd.cdc.gov/DDT_DPRP/Registry.aspx. Accessed April 8, 2020.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [8] CDC. Diabetes prevention recognition program: standards and operating procedures; 2018. Available from: https://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf. Accessed July 18, 2018.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
MDPP suppliers appear to be increasing since [time].
“While it is encouraging that MDPP suppliers since appear to be increasing,76”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [76] CMS. Medicare diabetes prevention program. Available from: https://data.cms.gov/Special-Programs-Initiatives/Medicare-Diabetes-Prevention-Program/vwz3-d6x2/data. Accessed July 9, 2020. Accessed May 31, 2020.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given
There are more initial no-shows for younger participants.
“plus more initial no-shows for low-income, racial/ethnic minority and younger participants”
Quote in the paperNot a substantial claim - Premisenone given
Weight loss is disparately low for women, younger adults, and racial/ethnic minority and low-income participants.
“Disparately low weight loss for women, younger adults, and racial/ethnic minority and low-income participants”
Quote in the paperNot a substantial claim - Interpretationreasoning
Insufficient reimbursement relative to costs may be a deterrent to maintaining and growing NDPP access, especially in high-need areas.
“Insufficient reimbursement relative to costs may be a deterrent to maintaining and growing NDPP access.”
- Also stated in: § Conclusion · hedged
“Insufficient reimbursement may be a deterrent to sustaining and growing access, especially in high-need areas”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · hedged
- Premisecitation
Medicare coverage began in April 2018.
“Notably, Medicare coverage began in April 2018,60 offering unprecedented opportunity to prevent diabetes among the estimated 46.6% of seniors with prediabetes.1”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Centers for Medicare & Medicaid Services (CMS) HHS. Medicare program; revisions to payment policies under the physician fee schedule and other revisions to part b for cy 2018; medicare shared savings program requirements; and medicare diabetes prevention program. final rule. Fed Regist. 2017;82(219):52976–53371.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given
There are more initial no-shows for low-income participants.
“plus more initial no-shows for low-income, racial/ethnic minority and younger participants”
Quote in the paperNot a substantial claim - Premisenone given
Younger adults are under-represented in the NDPP.
“Men and younger adults are under-represented”
Quote in the paperNot a substantial claim - Interpretationreasoning
Long-term sustainability of the NDPP is likely dependent on payer coverage.
“Long-term sustainability of the NDPP is likely dependent on payer coverage as initial dissemination appears largely supported by time-limited grant funding.”
Quote in the paperSubstantial claim- Rests on an assumption: Initial dissemination of the NDPP was largely supported by time-limited grant funding.
- Premisecitation
With Medicare, reported delivery costs (for first-year, in-person services) were 553-800 USD with average reimbursement of only 108-190 per participant, resulting in a gap of 363-792 USD.
“With Medicare, reported delivery costs (for first-year, in-person services) were 553–800 USD with average reimbursement of only 108–190 per participant,69,70 resulting in a gap of 363–792 USD.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [69] Ritchie, 2018, Med Care source
- cites [70] Parsons, 2018, Am J Manag Care
- Premisenone given
Pay-for-performance rates are below costs, especially for in-person delivery.
“Pay-for-performance rates are below costs, especially for in-person delivery”
Quote in the paperNot a substantial claim - Premisecitation
Early projections suggested that providing the NDPP could yield 5.7 billion USD in savings over 25 years.
“Early projections suggested that providing the NDPP could yield 5.7 billion USD in savings over 25 years.63”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Zhuo, 2012, Health Affairs source
- Interpretationnone given
The NDPP has notable effectiveness upon full participation and widespread insurance coverage.
“with notable effectiveness upon full participation and widespread insurance coverage.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Low reimbursement rates are likely detrimental to achieving a sufficient number of suppliers relative to the need.
“How or why low payment rates came to be established is unclear, especially given compelling evidence for ROI, yet they are likely detrimental to achieving a sufficient number of suppliers relative to the need.”
Quote in the paperSubstantial claim - Premisecitation
Severe shortages of MDPP sites were observed in states/territories with the largest populations of racial/ethnic minority beneficiaries.
“In fact, severe shortages of MDPP sites were observed in states/territories with largest populations of racial/ethnic minority beneficiaries,74”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [74] Ritchie ND, Sauder KA, Gritz RM. Medicare Diabetes Prevention Program: Where are the Suppliers? Am J Man Care. 2020; 26(6):294-e297.doi:10.37765/ajmc.2020.43496. source
- Interpretationcitation
Pay-for-performance reimbursement rates appear insufficient relative to reported costs, limiting sustainability.
“Pay-for-performance reimbursement rates appear insufficient relative to reported costs, limiting sustainability.”
Quote in the paperSubstantial claim - Interpretationreasoning
Online delivery alone does not appear to resolve effectiveness challenges.
“Thus, online delivery alone does not appear to resolve effectiveness challenges.”
Quote in the paperSubstantial claim - Premisenone given
Men are under-represented in the NDPP.
“Men and younger adults are under-represented”
Quote in the paperSubstantial claim - Premisecitation
One year after Medicare coverage began, there was on average only 1 MDPP site per 100,000 beneficiaries.
“Regarding Medicare suppliers, a report found relatively few locations where beneficiaries could receive services over a year after coverage began, with only 1 site per 100,000 beneficiaries on average.74”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [74] Ritchie ND, Sauder KA, Gritz RM. Medicare Diabetes Prevention Program: Where are the Suppliers? Am J Man Care. 2020; 26(6):294-e297.doi:10.37765/ajmc.2020.43496. source
- Interpretationcitation
Suppliers may be dissuaded from entering markets with especially high-risk populations who are less likely to achieve performance payment milestones.
“Another concern is that suppliers may be dissuaded from entering markets with especially high-risk populations who are less likely to achieve performance payment milestones.69,75”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisenone given
Weight regain begins during the NDPP intervention.
“Weight regain begins during intervention”
Quote in the paperNot a substantial claim - Premisenone given
There are more initial no-shows for racial/ethnic minority participants.
“plus more initial no-shows for low-income, racial/ethnic minority and younger participants”
Quote in the paperNot a substantial claim - Interpretationreasoning
A one-size-fits-all approach to the NDPP intervention is ineffective for the majority of participants.
“One-size-fits-all approach to intervention is ineffective for majority of participants”
Quote in the paperSubstantial claim - Premisenone given
Much or all of the lost weight is regained over time.
“much is all is regained over time”
Quote in the paperNot a substantial claim - Premisenone given
The NDPP reaches hundreds of thousands of individuals at risk for type 2 diabetes.
“reaching hundreds of thousands of individuals at risk for type 2 diabetes”
Quote in the paperSubstantial claim
- May combine two claims. 7
- Classified as probably not a substantial claim. 2
May combine two claims.
PremisecitationHigh initial no-shows among enrollees overall are 25-60%, and appear higher for racial/ethnic minority, low-income, and younger participants.
“Another challenge is high initial “no shows” among enrollees overall (25–60%),21–23 which appear higher yet for racial/ethnic minority, low-income, and younger participants.”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [21] Ritchie, 2018, Am J Health Promot source
- cites [22] Ritchie, 2017, Am J Prev Med source
- cites [23] Chambers, 2019, Diabetes Educ source
The Results (Characteristics Associated With Engagement; page unavailable) report 247 patients placed in a class who never attended and 747 who started—about 25% of those placed did not attend. The paper also reports lower engagement among younger patients and Medicaid patients, but it does not establish a 25–60% overall initial no-show range or show that initial no-show rates were higher for all three named demographic groups. (LLM, conf=0.78)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationA large study led by the American Medical Association found 56% enrollment upon point-of-care referrals to the NDPP and 11% enrollment using a retrospective, algorithm-based approach to referrals.
“A large study led by the American Medical Association found 56% enrollment upon point-of-care referrals to the NDPP and 11% enrollment using a retrospective, algorithm-based approach to referrals.16”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [16] Holliday, 2019, Prev Chronic Dis source
May combine two claims.
PremisecitationMen and younger individuals are under-represented in the NDPP; only 24.7% of NDPP participants were men in a 2019 CDC report.
“A challenge is that men and younger individuals are under-represented in the NDPP, and additional participation gaps exist for priority populations.”
- Also stated in: § Overcoming Challenges with Reach · plain
“In a 2019 CDC report, only 24.7% of NDPP participants were men,10 despite their higher prevalence of prediabetes compared to women (37.4% vs. 29.2%).1”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [10] Gruss, 2019, Curr Diab Rep source
- cites [1] CDC. National Diabetes Statistics Report, 2020: Estimates of Diabetes and Its Burden in the United States. Atlanta:GA: US Department of Health and Human Services; 2020.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Also stated in: § Overcoming Challenges with Reach · plain
May combine two claims.
PremisecitationReports show a promising 4.2% mean weight loss for in-person NDPP classes and 4.3% weight loss for virtual programs.
“Reports show a promising 4.2% mean weight loss for in-person NDPP classes3 and 4.3% weight loss for virtual programs.31”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [3] Ely, 2017, Diab Care source
- cites [31] Joiner, 2017, Prev Med source
The Results report 4.31% mean weight loss for DPP-based eHealth interventions with remote counselor support, matching the cited 4.3% after rounding. That figure applies to a subgroup, not virtual programs generally; the overall estimate for all eHealth interventions was 3.98%. The separate 4.2% in-person-class claim is attached to citation 3, not this source. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenThree-quarters of NDPP participants do not achieve the ≥5% weight loss goal.
“Three-quarters of participants do not achieve ≥5% weight loss goal”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMedian attendance is only 134 days, such that most participants complete less than half of the yearlong program.
“Yet median attendance is only 134 days, such that most participants complete less than half of the yearlong program.38”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38] Easterbrook, 1991, Lancet source
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenEffectiveness of the NDPP in terms of glycemia and incident diabetes is largely unknown.
“Effectiveness in terms of glycemia and incident diabetes is largely unknown”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningLow payments afford short-term benefits to payers but represent a missed opportunity for substantial long-term savings from reduced diabetes prevalence.
“Low payments afford short-term benefits to payers, but missed opportunity for substantial long-term savings from reduced diabetes prevalence”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation75% of US states/territories had no MDPP sites, <1 site per 100,000 beneficiaries, and/or availability limited to a single municipality.
“Specifically, 75% of US states/territories had no MDPP sites, <1 site per 100,000 beneficiaries, and/or availability limited to a single municipality.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [74] Ritchie ND, Sauder KA, Gritz RM. Medicare Diabetes Prevention Program: Where are the Suppliers? Am J Man Care. 2020; 26(6):294-e297.doi:10.37765/ajmc.2020.43496. source
The paper relies on this without support.
Initial dissemination of the NDPP was largely supported by time-limited grant funding.
“Long-term sustainability of the NDPP is likely dependent on payer coverage as initial dissemination appears largely supported by time-limited grant funding.”
The paper relies on this without support.
The Medicare Diabetes Prevention Program (MDPP) is near-identical to the in-person NDPP.
“The adapted Medicare-covered model, the Medicare Diabetes Prevention Program (MDPP), is near-identical to the in-person NDPP.”
The paper relies on this without support.
Medicare coverage of the NDPP remains under the umbrella of the Centers for Medicare and Medicaid Services Innovation Center.
“Medicare coverage of the NDPP remains under the umbrella of the Centers for Medicare and Medicaid Services Innovation Center”
The paper relies on this without support.
The lifestyle intervention underlying the NDPP is efficacious for preventing type 2 diabetes.
“translation of an efficacious lifestyle intervention”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Maximum Medicare reimbursement gap is overstated
MinorThe largest possible gap between the stated delivery costs and reimbursements is 800 − 108 = 692 USD, not 792 USD. The stated minimum gap of 363 USD is correct.
Reported 792 · recomputed 692
“With Medicare, reported delivery costs (for first-year, in-person services) were 553–800 USD with average reimbursement of only 108–190 per participant,69,70 resulting in a gap of 363–792 USD.”
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202 · see citing works
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109 · see citing works
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020 · cited 1× · see citing works
“vention from the Diabetes Prevention Program (DPP) trial, which demonstrated a 58% reduction in incidence over 3 years,(4) with benefits persisting up to 15 years.(5,6) Using”
BackgroundNutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496 · see citing works
Effect of weight loss with lifestyle intervention on risk of diabetes
Hamman, R. F., Wing, R. R., Edelstein, S. L., Lachin, J. M., Bray, G. A., Delahanty, L., Hoskin, M., Kriska, A. M., Mayer-Davis, E. J., Pi-Sunyer, X., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0560 · Cited by 1,344 · see citing works
Seligman, M. E. P. (1972) · Annual Review of Medicine · doi:10.1146/annurev.me.23.020172.002203 · Cited by 1,160 · see citing works
(2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00291-0 · Cited by 1,029 · see citing works
What are Health Disparities and Health Equity? We Need to Be Clear
Braveman, P. (2014) · Public Health Reports® · doi:10.1177/00333549141291s203 · Cited by 860 · see citing works
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725 · see citing works
Achieving Weight and Activity Goals Among Diabetes Prevention Program Lifestyle Participants
The Diabetes Prevention Program Research Group (2004) · Obesity Research · doi:10.1038/oby.2004.179 · Cited by 529 · see citing works
Size Acceptance and Intuitive Eating Improve Health for Obese, Female Chronic Dieters
Bacon, L., Stern, J. S., Van Loan, M. D., & Keim, N. L. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2005.03.011 · Cited by 483 · see citing works
Ely, E. K., Gruss, S. M., Luman, E. T., Gregg, E. W., Ali, M. K., Nhim, K., Rolka, D. B., & Albright, A. L. (2017) · Diabetes Care · doi:10.2337/dc16-2099 · Cited by 386 · see citing works
Maternal environment and the transgenerational cycle of obesity and diabetes.
Dabelea, D., & Crume, T. (2011) · Diabetes · doi:10.2337/db11-0400 · Cited by 347 · cited 1× · see citing works
“tion, and might even be leveraged to break the transgenerational disease cycle.(36)”
BackgroundSiu, A. L., & on behalf of the U.S. Preventive Services Task Force* (2015) · Annals of Internal Medicine · doi:10.7326/m15-2345 · Cited by 319 · see citing works
Preventing Type 2 Diabetes in Communities Across the U.S.
Albright, A. L., & Gregg, E. W. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.009 · Cited by 299 · see citing works
Joiner, K. L., Nam, S., & Whittemore, R. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.04.033 · Cited by 223 · see citing works
Adapting the Diabetes Prevention Program Lifestyle Intervention for Delivery in the Community
Ackermann, R. T., & Marrero, D. G. (2007) · The Diabetes Educator · doi:10.1177/0145721706297743 · Cited by 220 · see citing works
A Review of Interventions that Promote Eating by Internal Cues.
Schaefer, J. T., & Magnuson, A. B. (2014) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.12.024 · Cited by 206 · see citing works
Psychological and Behavioral Correlates of Baseline BMI in the Diabetes Prevention Program (DPP)
Delahanty, L. M., Meigs, J. B., Hayden, D. L., Williamson, D. A., & Nathan, D. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.1992 · Cited by 185 · see citing works
Gruss, S. M., Nhim, K., Gregg, E., Bell, M., Luman, E., & Albright, A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1200-z · Cited by 179 · see citing works
3. Prevention or Delay of Type 2 Diabetes: <i>Standards of Medical Care in Diabetes—2020</i>
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s003 · Cited by 162 · see citing works
Murray, J., Craigs, C. L., Hill, K. M., Honey, S., & House, A. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-120 · Cited by 138 · see citing works
Zhuo, X., Zhang, P., Gregg, E. W., Barker, L., Hoerger, T. J., Pearson-Clarke, T., & Albright, A. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1115 · Cited by 82 · see citing works
The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes
Fonda, S. J., Graham, C., Munakata, J., Powers, J. M., Price, D., & Vigersky, R. A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816628547 · Cited by 81 · see citing works
Review of Metformin Use for Type 2 Diabetes Prevention
Moin, T., Schmittdiel, J. A., Flory, J. H., Yeh, J., Karter, A. J., Kruge, L. E., Schillinger, D., Mangione, C. M., Herman, W. H., & Walker, E. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.038 · Cited by 75 · see citing works
Nhim, K., Gruss, S. M., Porterfield, D. S., Jacobs, S., Elkins, W., Luman, E. T., Van Aacken, S., Schumacher, P., & Albright, A. (2019) · Implementation Science · doi:10.1186/s13012-019-0928-9 · Cited by 71 · see citing works
Evidence and challenges for translation and population impact of the Diabetes Prevention Program.
Ackermann, R. T., & O’Brien, M. J. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-1293-4 · Cited by 62 · see citing works
Rural/urban disparities in access to the National Diabetes Prevention Program
Ariel-Donges, A. H., Gordon, E. L., Dixon, B. N., Eastman, A., Bauman, V., Ross, K. M., & Perri, M. G. (2019) · Translational Behavioral Medicine · doi:10.1093/tbm/ibz098 · Cited by 60 · see citing works
Impact Of The YMCA Of The USA Diabetes Prevention Program On Medicare Spending And Utilization
Alva, M. L., Hoerger, T. J., Jeyaraman, R., Amico, P. R., & Smith, L. R. (2017) · Health Affairs · doi:10.1377/hlthaff.2016.1307 · Cited by 59 · see citing works
Selecting an A1C Point-of-Care Instrument
Whitley, H. P., Yong, E. V., & Rasinen, C. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.3.201 · Cited by 55 · see citing works
Primary Care Providers’ Prediabetes Screening, Testing, and Referral Behaviors
Nhim, K., Khan, T., Gruss, S. M., Wozniak, G., Kirley, K., Schumacher, P., Luman, E. T., & Albright, A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.017 · Cited by 54 · see citing works
Ritchie, N. D., Christoe-Frazier, L., McFann, K. K., Havranek, E. P., & Pereira, R. I. (2018) · American Journal of Health Promotion · doi:10.1177/0890117117698623 · Cited by 53 · see citing works
Self-citationKhan, T., Tsipas, S., & Wozniak, G. D. (2017) · Population Health Management · doi:10.1089/pop.2016.0134 · Cited by 47 · see citing works
New Medicare Diabetes Prevention Coverage May Limit Beneficiary Access and Widen Health Disparities
Ritchie, N. D., & Gritz, R. M. (2018) · Medical Care · doi:10.1097/mlr.0000000000000981 · Cited by 35 · see citing works
Self-citationHarrison, C. R., Phimphasone-Brady, P., DiOrio, B., Raghuanath, S. G., Bright, R., Ritchie, N. D., & Sauder, K. A. (2020) · The Diabetes Educator · doi:10.1177/0145721720920252 · Cited by 35 · cited 1× · see citing works
“populations, and using a more flexible and interactive class format.(27,28) In turn, more empirical work is needed to fully demonstrate the potential benefits of these and”
MethodSelf-citationReach and Effectiveness of the National Diabetes Prevention Program for Young Women
Ritchie, N. D., Sauder, K. A., & Fabbri, S. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.06.013 · Cited by 34 · cited 2× · see citing works
“Specifically, Latino enrollees were half as likely to initially attend as compared to non-Hispanic white enrollees,(21) and women <40 years were about a quarter as likely to attend as their older counterparts (men were not included in this study).(22) Other data suggest lower show rates for Medicaid beneficiaries (69.”
BackgroundSelf-citationClinical Identification and Referral of Adults With Prediabetes to a Diabetes Prevention Program
Holliday, C. S., Williams, J., Salcedo, V., & Kandula, N. R. (2019) · Preventing Chronic Disease · doi:10.5888/pcd16.180540 · Cited by 32 · see citing works
Burd, C., Gruss, S. M., Albright, A. L., ZINA, A., Schumacher, P., & Alley, D. E. (2020) · Milbank Quarterly · doi:10.1111/1468-0009.12443 · Cited by 32 · see citing works
Availability of the National Diabetes Prevention Program in United States Counties, March 2017
Jayapaul-Philip, B., Dai, S., Kirtland, K., Haslam, A., & Nhim, K. (2018) · Preventing Chronic Disease · doi:10.5888/pcd15.180063 · Cited by 30 · see citing works
Rethinking the National Diabetes Prevention Program for Low-Income Whites
Ritchie, N. D., Sauder, K. A., Phimphasone‐Brady, P., & Amura, C. R. (2018) · Diabetes Care · doi:10.2337/dc17-2230 · Cited by 28 · see citing works
Self-citationVanEpps, E. M., Troxel, A. B., Villamil, E., Saulsgiver, K. A., Zhu, J., Chin, J.-Y., Matson, J. M., Anarella, J. P., Roohan, P. J., Gesten, F. C., et al. (2018) · American Journal of Health Promotion · doi:10.1177/0890117118783594 · Cited by 28 · see citing works
Benefits of Participating With a Partner in the National Diabetes Prevention Program
Ritchie, N. D., Baucom, K. J. W., & Sauder, K. A. (2019) · Diabetes Care · doi:10.2337/dc19-1489 · Cited by 28 · see citing works
Self-citationGilmer, T., O’Connor, P. J., Schiff, J. S., Taylor, G., Vazquez‐Benitez, G., Garrett, J. E., Vue‐Her, H., Rinn, S., Anderson, J., & DESAI, J. R. (2018) · Health Services Research · doi:10.1111/1475-6773.12973 · Cited by 25 · see citing works
(2018) · PubMed · Cited by 24 · see citing works
Fischer, H. H., Durfee, M. J., Raghunath, S., & Ritchie, N. D. (2019) · JMIR Diabetes · doi:10.2196/12985 · Cited by 24 · cited 1× · see citing works
“Reducing the intervention to delivery via short text messages demonstrated high retention but also was insufficiently effective.(43) Overall, further research appears needed, including to examine what specific virtual components are beneficial, and to what extent additional inperson or other “real” interaction with a…”
BackgroundSelf-citationSauder, K. A., Ritchie, N. D., Crowe, B., Cox, E., Hudson, M., & Wadhwa, S. (2020) · Translational Behavioral Medicine · doi:10.1093/tbm/ibaa048 · Cited by 24 · see citing works
Self-citationMedicare Diabetes Prevention Program: where are the suppliers?
(2020) · The American Journal of Managed Care · doi:10.37765/ajmc.2020.43496 · Cited by 24 · see citing works
Self-citationFoods, nutrients, and health: when will our policies catch up with nutrition science?
Mozaffarian, D. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30265-0 · Cited by 23 · cited 1× · see citing works
“Although the newest CDC-published curriculum (Prevent T2)(45) relaxes the dietary goal to ≤30% of calories from fat without required dietary monitoring, the NDPP continues to promote a low-fat diet that nutrition science has generally evolved away from.(46) Newer evidence suggests that various eating plans reduce risk…”
BackgroundBuilding Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults
Bowen, M. E., Schmittdiel, J. A., Kullgren, J. T., Ackermann, R. T., & O’Brien, M. J. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1090-5 · Cited by 23 · see citing works
Ackermann, R. T., Kang, R., Cooper, A. J., Liss, D. T., Holmes, A. M., Moran, M., & Saha, C. (2019) · Diabetes Care · doi:10.2337/dc18-2071 · Cited by 22 · see citing works
Realmuto, L., Kamler, A., Weiss, L., Gary‐Webb, T. L., Hodge, M. E., Pagán, J. A., & Walker, E. A. (2018) · American Journal of Men s Health · doi:10.1177/1557988318758786 · Cited by 21 · cited 1× · see citing works
“populations, and using a more flexible and interactive class format.(27,28) In turn, more empirical work is needed to fully demonstrate the potential benefits of these and”
MethodChambers, E. C., Gonzalez, J. S., Marquez, M. E., Parsons, A., & Rehm, C. D. (2019) · The Diabetes Educator · doi:10.1177/0145721719880503 · Cited by 14 · see citing works
Ritchie, N. D., Carroll, J. K., Holtrop, J. S., & Havranek, E. P. (2018) · Translational Behavioral Medicine · doi:10.1093/tbm/ibx021 · Cited by 12 · see citing works
Self-citationRitchie, N. D., & Swigert, T. J. (2016) · AADE in Practice · doi:10.1177/2325160316647707 · Cited by 11 · see citing works
Self-citationAlva, M. L. (2019) · American Journal of Health Promotion · doi:10.1177/0890117119848985 · Cited by 11 · see citing works
Ritchie, N. D., Havranek, E. P., Moore, S. L., & Pereira, R. I. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.02.005 · Cited by 9 · cited 1× · see citing works
“Another concern is that suppliers may be dissuaded from entering markets with especially high-risk populations who are less likely to achieve performance payment milestones.(69,75) In fact, severe shortages of MDPP sites were observed in states/territories with largest populations of racial/ethnic minority beneficiari…”
BackgroundSelf-citationRitchie, N. D., Raghunath, S., Durfee, M. J., & Fischer, H. H. (2020) · JMIR mhealth and uhealth · doi:10.2196/15478 · Cited by 7 · cited 5× · see citing works
“Payer coverage was established as an early priority and has required a remarkable collaboration of government, academic, community, healthcare, and payer sectors.9 For example, United Health Group was collaborating by 2009 to demonstrate payer involvement with an early translation of the NDPP in community settings of…”
BackgroundInfluentialSelf-citationKirkman, M. S., Tuncer, D. M., & Brown, C. E. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0086 · Cited by 5 · cited 2× · see citing works
“Moreover, when individuals become aware of having prediabetes, they are likely to take preventative action as 71% report efforts to reduce the likelihood of diabetes onset.(13) Media campaigns are a common approach to increase widespread risk awareness and promote the NDPP (i.”
BackgroundWorkgroup, A. T. M. C. D. A. D. P., Brokaw, S. M., Carpenedo, D., Campbell, P., Butcher, M. K., Helgerson, S. D., & Harwell, T. S. (2017) · Maternal and Child Health Journal · doi:10.1007/s10995-017-2420-y · Cited by 3 · see citing works
Sinclair-White, B. M., Nett, B., Ilagan, L., Cacal, S. L., Vu, U., Ching, L. K., Pirkle, C. M., & Keliikoa, L. B. (2020) · PubMed Central · Cited by 3 · see citing works
Ritchie, N. D., Fabbri, S., & Sauder, K. A. (2019) · Clinical Diabetes · doi:10.2337/cd18-0104 · Cited by 1 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 5
- Sinclair-White, 2020, Hawaii J Health Soc Welf, 79, 86
- Sauder KA, Ritchie ND, Crowe B, Cox E, Hudson M, Wadhwa S. Participation and weight loss in online National Diabetes Prevention Programs: a comparison of age and gender subgroups. Trans Beh Med. 2020;ibaa048. doi:10.1093/tbm/ibaa048. · DOI
- Alpizar, ADCES in Practice
- American Diabetes, 2020, Diab Care, 43, S32S36
- Parsons, 2018, Am J Manag Care, 24, 475
Cited by
Sorted by citations
Effects of a Digital Diabetes Prevention Program: An RCT
Katula, J. A., Dressler, E. V., Kittel, C. A., Harvin, L. N., Almeida, F. A., Wilson, K. E., Michaud, T. L., Porter, G. C., Brito, F. A., Goessl, C. L., et al. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.10.023 · Cited by 86 · see citing works
Golovaty, I., Ritchie, N. D., Tuomilehto, J. O., Mohan, V., Ali, M. K., Gregg, E. W., Bergman, M., & Moin, T. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110195 · Cited by 50 · see citing works
Self-citationLifestyle interventions for cardiometabolic health
Rutters, F., den Braver, N. R., Lakerveld, J., Mackenbach, J. D., van der Ploeg, H. P., Griffin, S. J., Elders, P. J. M., & Beulens, J. W. J. (2024) · Nature Medicine · doi:10.1038/s41591-024-03373-0 · Cited by 39 · see citing works
“%) particularly among ethnic minority groups, low-income groups and younger people 88 .”
Gruß, I. (2021) · The American Journal of Managed Care · doi:10.37765/ajmc.2021.88784 · Cited by 20 · see citing works
Diabetes Prevalence and Incidence Inequality Trends Among U.S. Adults, 2008–2021
Saelee, R., HORA, I. A., Pavkov, M. E., Imperatore, G., Chen, Y., Benoit, S. R., Holliday, C. S., & Bullard, K. M. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.07.009 · Cited by 19 · see citing works
Weber, M. B., Hassan, S., Quarells, R. C., & Shah, M. K. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.003 · Cited by 19 · see citing works
“51–53 Retention is markedly low in younger participants and racial/ethnic minorities.”
BackgroundKrishnan, A., Hadi, Y. B., Hutson, W. R., Thakkar, S. J., & Singh, S. P. (2022) · Pancreas · doi:10.1097/mpa.0000000000002197 · Cited by 18 · see citing works
Patient-Centered Goal-Setting in the National Diabetes Prevention Program: A Pilot Study
Ritchie, N. D., Sauder, K. A., Kaufmann, P. G., & Perreault, L. (2021) · Diabetes Care · doi:10.2337/dc21-0677 · Cited by 15 · see citing works
Self-citationSpence, R., Sisson, E. M., & Dixon, D. L. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.03.020 · Cited by 12 · see citing works
Looking back: a review of policy implications for exercise oncology
Kennedy, M. A., Potiaumpai, M., Maitin‐Shepard, M., Wilson, C. M., Campbell, A., Schwartz, A. L., Gorzelitz, J., Caru, M., Grimmett, C., & Schmitz, K. H. (2023) · JNCI Monographs · doi:10.1093/jncimonographs/lgad002 · Cited by 11 · see citing works
Ng, B. P., ELY, E., Papali'i, M., & Cannon, M. J. (2024) · Journal of Diabetes Research · doi:10.1155/2024/8461704 · Cited by 11 · see citing works
“In general, these fi ndings are consistent with previous studies [16, 20, 25, 29, 37, 38].”
ResultWagner, J. M., Reinkemeier, F., Wallner, C., Dadras, M., Dittfeld, S., Drysch, M., Sogorski, A., von Glinski, M., Lehnhardt, M., Behr, B., et al. (2022) · Life · doi:10.3390/life12020134 · Cited by 11 · see citing works
“Considering that diabetes concerns 13% of US adults and that an additional nearly 35% of adults are estimated to have increased blood glucose that may develop to type 2 diabetes without intervention, an ever increasing health and economic burden is looming [9].”
BackgroundHerman, W. H., Joiner, K. L., Hurst, T. E., & McEwen, L. N. (2021) · Diabetes Care · doi:10.2337/dc20-3112 · Cited by 10 · see citing works
“Asian 1,322 (8) 976 (8) 346 (8) 97 (8) 249 (7) Black 817 (5) 741 (7) 76 (2) 31 (3) 45 (1) White 14,402 (86) 10,334 (85) 4,068 (89) 1,076 (88) 2,992 (90) Other 212 (1) 154 (1) 58 (1) 19 (2) 39 (1)”
MethodInfluentialEngagement in the National Diabetes Prevention Program Among Hispanic Men
Gonzalez, C. J., Perez‐Mejia, C. N., Hernandez, N., Flaxman, H. R., Stephenson-Hunter, C., Gil, E., León, E. D., Formagini, T. D. B., Chambers, E. C., Shapiro, M. F., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.15046 · Cited by 9 · see citing works
Whitaker, M., Aguirre, M. C., Chavez, M. G., Beaulieu, E., Arones, Y. B., Gershenoff, D. C., Hinton, K., Klein, N., Uwizeye, J. M., Napia, E. E., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068623 · Cited by 8 · see citing works
Self-citationMadrigal, L., Haardörfer, R., Kegler, M. C., Piper, S., Blais, L. M., Weber, M. B., & Escoffery, C. (2023) · Preventing Chronic Disease · doi:10.5888/pcd20.230067 · Cited by 7 · see citing works
Lower-Intensity Interventions for Prediabetes: A Systematic Review
Tseng, E., Lam, K. Y., Meza, K. A., O’Brien, M. J., & Maruthur, N. M. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.05.012 · Cited by 7 · see citing works
Madrigal, L., Haardörfer, R., Kegler, M. C., Piper, S., Blais, L. M., Weber, M. B., & Escoffery, C. (2023) · Implementation Science Communications · doi:10.1186/s43058-023-00522-3 · Cited by 6 · see citing works
“There have also been a number of adaptations and strategies to address the disparities in reach regarding racial and ethnic minorities and men as well [2].”
BackgroundResultInfluentialChang, L., Fukuoka, Y., Aouizerat, B. E., et al. (2023) · JMIR Diabetes · doi:10.2196/44018 · Cited by 7 · see citing works
Stephenson-Hunter, C., Pacheco, G., Kim, R. S., Gao, Q., Hosgood, H. D., & Chambers, E. C. (2023) · Preventing Chronic Disease · doi:10.5888/pcd20.230072 · Cited by 6 · see citing works
Teo, J. Y. C., Ramachandran, H. J., Jiang, Y., Seah, A. C. W., Lim, S. T., Nguyen, H. D., & Wang, W. (2023) · Journal of Clinical Nursing · doi:10.1111/jocn.16649 · Cited by 6 · see citing works
Diabetes: A Global Health Concern and Potential Strategies to Reduce Its Prevalence
Tayyab, S. L., Seher, W., Hussain, K., & Murtaza, I. (2024) · Integrated science · doi:10.1007/978-3-031-64288-3_14 · Cited by 5 · see citing works
Mirsky, J., & Artz, K. E. (2023) · Healthcare · doi:10.1016/j.hjdsi.2023.100723 · Cited by 5 · see citing works
Ritchie, N. D., & Turk, M. T. (2024) · mHealth · doi:10.21037/mhealth-23-37 · Cited by 6 · see citing works
“Recruitment is often a challenge even with in-person delivery of DPPs to participants of all ages (46), and this challenge has also applied when suppliers are recruiting older adults (18,47,48).”
BackgroundSelf-citationKHOSROVANEH, K. L., Kalesnikava, V. A., & Mezuk, B. R. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-089922 · Cited by 4 · see citing works
Lifestyle Medicine in Diabetes Care: The Lifedoc Health Model
Nieto-Martínez, R. E., Neira, C. P., de Oliveira, D., Rodriguez, A. E. V., Neira, A., Velásquez-Rodríguez, P., Garcia, G., Gonzalez-Rivas, J. P., Mechanick, J. I., & Velasquez‐Mieyer, P. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221103470 · Cited by 5 · see citing works
Napoleone, J. M., Miller, R. G., Devaraj, S. M., Rockette‐Wagner, B., Arena, V. C., Venditti, E. M., Kramer, M. K., Strotmeyer, E. S., & Kriska, A. M. (2021) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106211023990 · Cited by 5 · see citing works
Sauder, K. A., Gamalski, K., DeRoeck, J., Vasquez, F. P., Dabelea, D., Glueck, D. H., Catenacci, V. A., Fabbri, S., & Ritchie, N. D. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107305 · Cited by 3 · see citing works
Self-citationRitchie, N. D., Turk, M. T., Holtrop, J. S., Durfee, M. J., Dickinson, L. M., & Kaufmann, P. G. (2024) · Journal of Clinical and Translational Science · doi:10.1017/cts.2024.11 · Cited by 3 · see citing works
“The goal was detecting differences in enrollment success with the in-person vs. remote study protocol, rather than other potential factors that could influence enrollment [14].”
Self-citationFormagini, T. D. B., Rezwan, A., Rodriguez, D., Venkataramani, M., O’Brien, M. J., Arredondo, E. M., & Ng, B. P. (2025) · Archives of Public Health · doi:10.1186/s13690-025-01532-4 · Cited by 3 · see citing works
“…and other essential factors such as additional costs related to the recruitment and retention of participants, staff training and development, program materials and resources, technology infrastructure for virtual delivery, and ongoing evaluation and monitoring of program effectiveness [34].”
InfluentialHaseldine, C., Pallin, J. A., Kearney, P. M., McHugh, S., Riordan, F., Cotterill, S., & O’Donoghue, G. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-090105 · Cited by 3 · see citing works
“22 23 Therefore, the perspectives of this broader HCW group need investigation.”
Mandelbaum, J., Brightharp, C. L., Myers, K. G., et al. (2023) · Preventing Chronic Disease · doi:10.5888/pcd20.220199 · Cited by 3 · see citing works
Effectiveness of the National Diabetes Prevention Program After Gestational Diabetes
Ritchie, N. D., Seely, E. W., Nicklas, J. M., & Levkoff, S. E. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.03.006 · Cited by 3 · see citing works
Self-citationDiabetes in Women After Gestational Diabetes: A Missed Opportunity for Prevention
Seely, E. W., Ritchie, N. D., Nicklas, J. M., & Levkoff, S. E. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2022.08.009 · Cited by 3 · see citing works
Self-citationMandelbaum, J., Myers, K. G., Brightharp, C. L., et al. (2021) · Health Education & Behavior · doi:10.1177/10901981211057538 · Cited by 3 · see citing works
“The NDPP is a structured lifestyle change program that has been shown to prevent or delay type 2 diabetes among people at high risk (Knowler et al., 2002; Ritchie et al., 2020).”
BackgroundCarter, E. W., Vadari, H. S., STOLL, S. C., Rogers, B., Resnicow, K., Heisler, M., Herman, W. H., Kim, H. M., McEwen, L. N., Volpp, K. G. M., et al. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.107038 · Cited by 2 · see citing works
Haseldine, C., O’Donoghue, G., Kearney, P. M., Riordan, F., Cotterill, S., & McHugh, S. (2024) · HRB Open Research · doi:10.12688/hrbopenres.13702.2 · Cited by 2 · see citing works
“In the United States DPPs are delivered by community-based organisations, pharmacies, as well as health clinics 27 and programmes are available online 28 .”
Seguridad Alimentaria en el Hogar y el control glucémico en pacientes diabéticos
Ibarra, E. O., Monteros, C. A. F., & Ibarra, I. H. O. (2021) · Educación y Salud Boletín Científico Instituto de Ciencias de la Salud Universidad Autónoma del Estado de Hidalgo · doi:10.29057/icsa.v10i19.7230 · Cited by 2 · see citing works
Haseldine, C., O’Donoghue, G., Kearney, P. M., Riordan, F., Cotterill, S., & McHugh, S. (2023) · HRB Open Research · doi:10.12688/hrbopenres.13702.1 · Cited by 2 · see citing works
Patient-Centered Goal Setting to Advance Health Equity in Diabetes Prevention
Ritchie, N. D., Alshabani, N., & Cervantes, L. (2023) · ADCES in Practice · doi:10.1177/2633559x231163839 · Cited by 2 · see citing works
Self-citationImprovement of Decision Support System for Rail Depot Planning
Beygo, B. (2013) · Cited by 2 · see citing works
Stephenson-Hunter, C., Gonzalez, C. J., Franco, S., Hashmi, M., Tisor, O., & González, C. M. (2024) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2024-000932 · Cited by 1 · see citing works
Advancing Type 2 Diabetes Prevention through Text-Messaging Interventions: A Narrative Review
Formagini, T. D. B., Gonzalez, C. J., Dias, J., Arredondo, E. M., Hekler, E. B., & O’Brien, M. J. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01568-w · Cited by 1 · see citing works
“Current reimbursement payments often do not cover the full cost of the program, hindering its sustainability [ 18 , 19 ].”
Michels, D., Walter, C., Grathwohl-Karl, A., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-109248 · Cited by 1 · see citing works
Mirsky, J. B., Sung, M., Choudhry, N. K., Crum, K. L., Rahmoune, A., Hanken, K. E., Lauffenburger, J. C., & Haff, N. (2026) · NEJM Catalyst · doi:10.1056/cat.25.0284 · Cited by 1 · see citing works
Health Equity in Dissemination and Implementation Science
Fitzpatrick, S. L., Glenn, B. A., Duru, O. K., & Ford, C. L. (2023) · doi:10.1093/oso/9780197660690.003.0025 · Cited by 1 · see citing works
If we build it, will they come? Exploring feasibility of community pharmacy diabetes care services
Nuffer, W. A., Gallegos, D., Segerstrom‐Nunez, A., & Schwander, K. (2025) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.2074 · Cited by 1 · see citing works
Wiggins, M., Round, J. A., & Kirwin, E. M. (2025) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462325100172 · Cited by 1 · see citing works
“We estimated intervention compliance based on retention and participation in the US National DPP (59;60).”
Barriers for Individuals with Prediabetes from Enrolling in the YMCA’s Diabetes Prevention Program
Pardakhtim, S., Kourehpazan, N., & Claussen, R. C. (2021)
HIV, Diabetes, and Cardiometabolic Comorbidities: Optimal Health Outcomes
Stinnett, D., Stivers, T., & Hieronymus, L. B. (2023) · ADCES in Practice · doi:10.1177/2633559x221150797
Khoshnazar, S. M., Najafipour, H., SoltaniNejad, L., Pezeshki, S., & Yousefzadeh, G. (2023) · Italian Journal of Medicine · doi:10.4081/itjm.2023.1642
Smith, E. J., Apfelbaum, L. J., Yeh, M., et al. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-10129-y
“Pay-for-performance reimbursement rates are insufficient and can leave an up to $800 deficit per participant between actual cost of implementation and reimbursement [19, 26, 27].”
BackgroundHealth and wellness coaching for Type 2 diabetes prevention: A Systematic Scoping Review Protocol
Mejía-Lancheros, C., Hafiz, Z. H., Hwang, M., Sherifali, D., Carte, A. J., Malhotra, G., Kappor, A., & Zenlea, I. S. (2023) · doi:10.37766/inplasy2023.11.0004
Remembering What We Always Knew: Development of an Indigenous Diabetes Prevention Model
Peng, B., Welshons, K., Adler, T., Kim, H., & Blue, E. J. M. (2025) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2025.104570
“Although these programs produce signi fi cant positive outcomes in terms of improved health indicators [9], they fail to consider and report if collecting health metrics such as blood pressure and BMI cause discomfort or reinforce historical trauma.”
Chavez, M. G., Parsons, H., Gutner, C. A., Asnaani, A., & Baucom, K. J. W. (2025) · Translational Behavioral Medicine · doi:10.1093/tbm/ibaf024 · Cited by 1 · see citing works
“This drop-off in participation is problematic because sessions attended predict the percentage of body weight lost [8].”
Self-citationLiu, W., Ma, G., Zhu, X., Liufu, Q., & Lai, J. (2025) · Archives of Medical Science · doi:10.5114/aoms/207710
Wagner, G., Koon, L. M., Smith, P. R., Suire, K. B., Hastert, M. C., Donnelly, J. E., Olfert, M. D., Estabrooks, P. A., & Gorczyca, A. M. (2025) · JMIR Formative Research · doi:10.2196/70406
“This presents a dilemma: participants seek more structured information, while the professional consensus suggests that rigid guidelines are ineffective in fostering long-term behavior change, a conflict difficult to resolve within the National DPP framework [36,38].”
Olchanski, N., Weidner, S. B., Lin, C.-H., & Kent, D. M. (2025) · medRxiv · doi:10.1101/2025.10.02.25337195
Madrigal, L., Haardörfer, R., Kegler, M. C., Piper, S., Blais, L. M., Weber, M. B., & Escoffery, C. (2024) · Figshare · doi:10.6084/m9.figshare.24586310
Smith, E. J., Apfelbaum, L. J., Yeh, M.-C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26631565
Smith, E. J., Apfelbaum, L. J., Yeh, M.-C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24439451
Madrigal, L., Haardörfer, R., Kegler, M. C., Piper, S., Blais, L. M., Weber, M. B., & Escoffery, C. (2024) · Figshare · doi:10.6084/m9.figshare.26641915
Madrigal, L., Haardörfer, R., Kegler, M. C., Piper, S., Blais, L. M., Weber, M. B., & Escoffery, C. (2024) · Figshare · doi:10.6084/m9.figshare.26641918
Smith, E. J., Apfelbaum, L. J., Yeh, M.-C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24439330
Madrigal, L., Haardörfer, R., Kegler, M. C., Piper, S., Blais, L. M., Weber, M. B., & Escoffery, C. (2023) · Figshare · doi:10.6084/m9.figshare.24586213
Barriers and assets in diabetes prevention: A community-based assessment in a Latino population
Cruz, M., Raine, L. M., Ortiz, L., & Alemi, Q. (2026) · Social Work in Health Care · doi:10.1080/00981389.2026.2648201
“Research underscores that many existing strategies – including provider referrals, educational outreach, motivational interviewing, and non-monetary incentives – have had limited success in improving retention and participation among prediabetic Latino adults (Ritchie et al., 2020).”
Pollard, K. J., Ames, M. L., Anderson, K., Gobble, J. E., Moore, S., Patel, P. M., Pauly, K. R., Staffier, K. L., Tondapu, P., & Karlsen, M. C. (2026) · American Journal of Lifestyle Medicine · doi:10.1177/15598276261438370
Geographic Analysis of Access to the National Diabetes Prevention Program in New York State
Vrany, E. A., Chiuzan, C. C., Oh, E. J., Ephraim, P. L., Austin, R., Brissette, I. F., Millstein, S. L., & Fitzpatrick, S. L. (2026) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2026.103500
“Furthermore, access to and engagement in National DPP has been suboptimal, especially among racial and ethnic minoritized, low SES, and rural communities (Chambers et al., 2019; Ritchie et al., 2020; Ariel-Donges et al., 2020).”
Michels, D., Walter, C., Grathwohl-Karl, A., Pfau, J., Haumann, H., Joos, S., & Fröhlich, D. (2026) · BMC Public Health · doi:10.1186/s12889-026-28319-8
H, D. B. M. P., Ruscitti, B., Zhu, S., Lee, R., & Nguyen, T. (2026) · Journal of Prevention · doi:10.1007/s10935-026-00949-z
- Authors
- Ritchie, N. D., Baucom, K. J., & Sauder, K. A.
- Affiliations
- Denver Health Medical Center (US)
- University of Utah (US)
- University of Colorado Anschutz (US)
- Corresponding author
- Ritchie, Natalie D
- Venue
- Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2020-08
- Volume
- Volume 13
- Pages
- 2949-2957
- ISSN
- 1178-7007 (ISSN-L)
- PMC
- PMC7445538
- OpenAlex
- W3079063442
- Cited by
- 70
- References
- 62
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 13 · 2023: 22 · 2022: 8 · 2021: 8 · 2013: 1
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diabetes Metabolic Syndrome and Obesity (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by-nc)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK115820, R01DK119478)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- National Diabetes Prevention Program, type 2 diabetes prevention, intensive lifestyle intervention, weight loss, diabetes incidence, program reach, program effectiveness, program sustainability, health disparities, glycemic control, metformin, insurance coverage
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-16.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-16.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
